Intrinsiqs

Is Verrica Pharmaceuticals Inc. overvalued?

Verrica Pharmaceuticals Inc. (VRCA) — key valuation metrics and fundamentals.

No verdict
Price
$3.56
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$61.2M
Dividend yield
0.0%
Return on equity
-444.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares VRCA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.